Symposium Body Control – Legal Regulatory Perspectives on Biometrics and Biobanks 22-23 November 2007
ELSA-research initiated by the Research Council of Norway (RCN)
Senior adviser Helge Rynning, Division for strategic priorites, RCN
ELSA RESEARCH - RCN
- Ethical, legal and social aspects of biotechnology (ELSA – Norway); 2002-2007
- Functional genomics in Norway (FUGE) - Nanotechnology and new materials,
nanoscience and integration (NANOMAT) Ethical, legal and social aspects of
biotechnology, nanotechnology and cognitive science (2007-2012)
ELSA II (2007-2012)
Planning group, report June 2007
Steering Committee appointed, international profile
Programme plan Spring 2008
Planning group, research challenges
Science, technology and society Democracy, justice and power Language, dissemination,dialogue Governance and priorities Medicine and health: Prevention,
enhancement and design Food,environment and nature Privacy, consent Risk, precautionary principle
Programme Board
(Chair) Geir Gogstad, Ph.D.; Department Head, Rikshospitalet-Radiumhospitalet Medical Centre
Professor Peter Aleström, Norwegian School of Veterinary Science
Professor Rigmor Austgulen, Norwegian University of Science and Technology (NTNU)
Professor Ruth Chadwick, Cardiff University; Director of CESAGen (Centre for Economic and Social Aspects of Genomics), Wales
Professor Richard A.L. Jones, University of Sheffield, England
Programme Board (cont)
Fabrice Lapique, Research Manager, SINTEF Materials and Chemistry
Professor Arie Rip, University of Twente, The Netherlands
Associate Professor Andreas Roepstorff, University of Århus, Denmark
Professor Henriette Sinding Aasen, University of Bergen
Dr. Ilina Singh, London School of Economics and Political Science, England